Matthew Heimermann
Stock Analyst at Citi
(3.92)
# 2,022
Out of 5,099 analysts
107
Total ratings
76.5%
Success rate
10%
Average return
Main Sectors:
Stocks Rated by Matthew Heimermann
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AJG Arthur J. Gallagher & Co. | Downgraded: Hold | $285 → $300 | $273.45 | +9.71% | 8 | Nov 3, 2026 | |
| PS Pershing Square | Reiterated: Sell | $45 | $46.66 | -3.56% | 5 | Nov 3, 2026 | |
| EG Everest Group | Reiterated: Hold | $415 → $445 | $410.57 | +8.39% | 4 | Nov 2, 2026 | |
| ACGL Arch Capital Group | Reiterated: Buy | $123 → $125 | $107.79 | +15.97% | 5 | Oct 29, 2026 | |
| RNR RenaissanceRe Holdings | Reiterated: Buy | $370 → $385 | $346.84 | +11.00% | 8 | Oct 29, 2026 | |
| BRO Brown & Brown | Reiterated: Hold | $79 → $76 | $70.92 | +7.16% | 8 | Oct 28, 2026 | |
| ASIC Ategrity Specialty Insurance Company Holdings | Reiterated: Hold | $29 → $29 | $24.11 | +20.28% | 6 | Oct 22, 2026 | |
| CB Chubb | Rated: Buy | $395 → $405 | $366.54 | +10.49% | 6 | Oct 22, 2026 | |
| TRV The Travelers Companies | Reiterated: Hold | $385 → $395 | $395.41 | -0.10% | 5 | Oct 19, 2026 | |
| MRSH Marsh & McLennan Companies | Reiterated: Hold | $200 → $203 | $203.63 | -0.31% | 8 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $240 → $215 | $261.50 | -17.78% | 7 | Oct 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $435 | $330.16 | +31.75% | 9 | Sep 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $33 → $39 | $36.47 | +6.94% | 3 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $300 → $345 | $327.66 | +5.29% | 6 | Aug 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 → $54 | $45.73 | +16.99% | 6 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $261 | $229.11 | +13.92% | 7 | Jul 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $85 → $88 | $80.53 | +9.28% | 3 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $138 → $143 | $134.92 | +5.99% | 3 | Feb 4, 2026 |
Arthur J. Gallagher & Co.
Nov 3, 2026
Downgraded: Hold
Price Target: $285 → $300
Current: $273.45
Upside: +9.71%
Pershing Square
Nov 3, 2026
Reiterated: Sell
Price Target: $45
Current: $46.66
Upside: -3.56%
Everest Group
Nov 2, 2026
Reiterated: Hold
Price Target: $415 → $445
Current: $410.57
Upside: +8.39%
Arch Capital Group
Oct 29, 2026
Reiterated: Buy
Price Target: $123 → $125
Current: $107.79
Upside: +15.97%
RenaissanceRe Holdings
Oct 29, 2026
Reiterated: Buy
Price Target: $370 → $385
Current: $346.84
Upside: +11.00%
Brown & Brown
Oct 28, 2026
Reiterated: Hold
Price Target: $79 → $76
Current: $70.92
Upside: +7.16%
Ategrity Specialty Insurance Company Holdings
Oct 22, 2026
Reiterated: Hold
Price Target: $29 → $29
Current: $24.11
Upside: +20.28%
Chubb
Oct 22, 2026
Rated: Buy
Price Target: $395 → $405
Current: $366.54
Upside: +10.49%
The Travelers Companies
Oct 19, 2026
Reiterated: Hold
Price Target: $385 → $395
Current: $395.41
Upside: -0.10%
Marsh & McLennan Companies
Oct 16, 2026
Reiterated: Hold
Price Target: $200 → $203
Current: $203.63
Upside: -0.31%
Oct 5, 2026
Reiterated: Sell
Price Target: $240 → $215
Current: $261.50
Upside: -17.78%
Sep 21, 2026
Initiated Coverage: Buy
Price Target: $435
Current: $330.16
Upside: +31.75%
Aug 12, 2026
Reiterated: Hold
Price Target: $33 → $39
Current: $36.47
Upside: +6.94%
Aug 4, 2026
Downgraded: Hold
Price Target: $300 → $345
Current: $327.66
Upside: +5.29%
Aug 3, 2026
Reiterated: Buy
Price Target: $50 → $54
Current: $45.73
Upside: +16.99%
Jul 15, 2026
Reiterated: Buy
Price Target: $261
Current: $229.11
Upside: +13.92%
May 4, 2026
Rated: Hold
Price Target: $85 → $88
Current: $80.53
Upside: +9.28%
Feb 4, 2026
Reiterated: Hold
Price Target: $138 → $143
Current: $134.92
Upside: +5.99%